Defective monocyte function in patients with systemic lupus erythematosus

Area of Science:

• Immunology
• Cell Biology
• Rheumatology

Background:

• Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by immune system dysregulation.
• Defects in immune cell function, particularly phagocytosis and proliferation, are observed in SLE patients.
• The role of adherent cells in SLE pathogenesis requires further elucidation.

Purpose of the Study:

• To investigate the phagocytic and proliferative activity of peripheral blood adherent cells in SLE patients.
• To determine the contribution of adherent cell abnormalities to impaired mononuclear cell proliferation in SLE.
• To compare immune cell function in SLE patients with healthy controls and non-SLE patients on corticosteroid therapy.

Main Methods:

• Assessed phagocytic activity of peripheral blood adherent cells from SLE patients and controls.
• Measured hexose monophosphate shunt and glycolytic activity in monocytes.
• Evaluated proliferative responses of mononuclear cells after sodium periodate (NaIO4) activation.
• Performed co-culture experiments with SLE and normal lymphocytes and adherent cells.

Main Results:

• Peripheral blood adherent cells from SLE patients showed significantly reduced phagocytic activity compared to controls.
• Both resting and phagocytosing monocytes from SLE patients exhibited decreased metabolic activity (hexose monophosphate shunt and glycolytic pathways).
• Mononuclear cells from SLE patients displayed impaired proliferation following NaIO4 activation, linked to an adherent cell abnormality.

Conclusions:

• Adherent cell dysfunction, including reduced phagocytosis and impaired metabolic activity, is a key feature of SLE.
• An abnormality in adherent cells directly contributes to the defective proliferative capacity of mononuclear cells in SLE patients.
• These findings highlight adherent cells as a potential therapeutic target in managing SLE immune dysregulation.